Hong Kong - Ivabradine (HCl) Tablets

This is a business opportunity from an overseas buyer. Pitch for the business and explain how your company meets their requirements.

A Hong Kong authority is tendering for the supply of Ivabradine (HCl) tablets in 5mg and 7.5mg doses.

Details

Opportunity closing date
15 March 2025
Opportunity publication date
06 February 2025
Opportunity type
Public Sector
Industry
Healthcare services
Enquiries received
1
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

You must be able to supply a minimum of 2,240,000 tablets of Ivabradine (HCl) 5mg and 560,000 tablets of Ivabradine (HCl) 7.5mg. Tablets must be in blister or strip packaging. All packaging must include an English translation, and the expiration date must be clear and in English or Arabic numerals. This is a 3-year contract, with a possible 24-month extension. You must be a UK-registered company.

The opportunity closing date is 19 March 2025, 12:00 pm (Hong Kong Time).

Opportunity closing date
15 March 2025
Value of contract
to be confirmed
The buyer is happy to talk to
manufacturers, wholesalers, distributors, agents

Express your interest

Express your interest to the Department for Business and Trade team in Hong Kong.

All submissions will be reviewed and you will be notified of any potential next steps. You can only express your interest if you are a UK registered company.

This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.

Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.

Express your interest
Is there anything wrong with this page?